ID   OKK-1
AC   CVCL_A5XG
DR   Wikidata; Q107116604
RX   PubMed=690749;
RX   PubMed=1842870;
RX   PubMed=3489826;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=690749; DOI=10.3950/jibiinkoka.81.587;
RA   Ishida M.;
RT   "Cultured human cancerous cells -- established cell line originating
RT   from the human paranasal sinus.";
RL   Nihon Jibiinkoka Gakkai Kaiho 81:587-603(1978).
//
RX   PubMed=1842870; DOI=10.3109/00016489109135000;
RA   Cho J., Sugiyama M., Uekawa M., Nakai Y., Tamura T., Nakajima T.,
RA   Onoyama Y.;
RT   "Synergistic effect of irradiation and hyperthermia on established
RT   cell lines derived from maxillary carcinoma. Report I.";
RL   Acta Oto-Laryngol. Suppl. 486:224-233(1991).
//
RX   PubMed=3489826; DOI=10.3950/jibiinkoka.89.744;
RA   Takeda T.;
RT   "Experimental approach to immunotherapy in head and neck malignant
RT   tumors -- antitumor efficacy by lymphokine activated human peripheral
RT   blood lymphocytes.";
RL   Nihon Jibiinkoka Gakkai Kaiho 89:744-753(1986).
//